 fig. S1 . Schematic diagram of the BBN-induced mouse BCa model.  fig. S2 . KDM6A functions as a demethylase-dependent and demethylaseindependent tumor suppressor of BCa.  fig. S3 . Schematic diagram and results of the BBN-induced BCa regimen of urothelium-specific Kdm6a cKO mice.  fig. S4 . KDM6A expression levels in cancer samples are higher among female than male patients.  fig. S5 . Kaplan-Meier analysis of overall survival of cancer patients stratified by KDM6A expression levels.  fig. S6 . Candidate XCI escape genes and their mutation rates in human BCa.  fig. S7 . Expression of the candidate XCI escape genes in BCa tissues from female and male patients.  fig. S8 . Kaplan-Meier analysis of overall survival of cancer patients stratified by expression levels of the candidate XCI escape genes.  fig. S9 . A model of molecular basis underlying the sex differences in cancer.  table S1. BCa HR of mice with different sex chromosome complement (XX versus XY) or Kdm6a status (wt versus mut).

